Trials / Conditions / Childhood Synovial Sarcoma

Childhood Synovial Sarcoma

7 registered clinical trials studyying Childhood Synovial Sarcoma.

Status	Trial	Sponsor	Phase
Completed	Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas NCT01567046	Children's Oncology Group	—
Completed	Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma NCT01614795	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors NCT00831844	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta NCT00720174	National Cancer Institute (NCI)	Phase 1
Completed	Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft NCT00346164	Children's Oncology Group	Phase 3
Completed	Ixabepilone in Treating Young Patients With Refractory Solid Tumors NCT00331643	National Cancer Institute (NCI)	Phase 2
Completed	Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood NCT00030667	National Cancer Institute (NCI)	Phase 2